홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

덱스메틸페니데이트

Dexmethylphenidate

HCID 154101
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
40431-64-9
표준 SMILES
COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1
InChIKey
DUGOZIWVEXMGBE-CHWSQXEVSA-N
분자식
C14H19NO2
평균 분자량
233.31 g/mol
단동위원소 질량
233.14157885

개요

Dexmethylphenidate is a methyl phenyl(piperidin-2-yl)acetate in which both stereocentres have R configuration. It is the active enantiomer in the racemic drug methylphenidate. It has a role as an adrenergic agent. It is an enantiomer of a methyl (S)-phenyl[(S)-piperidin-2-yl]acetate.

이름 및 식별자

우선 이름
Dexmethylphenidate
IUPAC
methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate
현지명
덱스메틸페니데이트
영어명
dexmethylphenidate
분자식
C14H19NO2
분자량
233.31

이름 및 동의어

Dexmethylphenidated-threo-Methylphenidate(+)-threo-Methylphenidate40431-64-9dexmetilfenidatoAttenadeD-TMPM32RH9MFGPdexmethylphenidatummethyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetateCHEBI:51860methyl (R)-phenyl[(R)-piperidin-2-yl]acetate
이름 더 보기
덱스메틸페니데이트d-threo-FormDexaMethylphenedateDexmethylphenidate D9D-threo-Methylphenidate DISCONTINUED, offer M3256752-Piperidineacetic acid, α-phenyl-, methyl ester, (αR,2R)-
DTXSID70893769methyl (2R)-phenyl[(2R)-piperidin-2-yl]acetate2-Piperidineacetic acid, alpha-phenyl-, methyl ester, (alphaR,2R)-METHYL (2R)-PHENYL((2R)-PIPERIDIN-2-YL)ACETATEmethyl (R)-phenyl((R)-piperidin-2-yl)acetatemethyl (2R)-2-phenyl-2-((2R)-piperidin-2-yl)acetateRefChem:56469Methylphenidate d-threo-

데이터베이스 식별자

CAS
40431-64-9
PubChem CID
154101

물성

구조 계산 물성보충 중

XLogP
0.2
극성 표면적
38.3 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
4
무거운 원자 수
17
형식 전하
0
복잡도
249

실험 및 물리화학적 성질

Drugs · 2건

DEA NFLIS-Drug Category -> Piperidines/PEA

DEA NFLIS-Drug Category -> Depressants and Tranquilizers

Human DrugsBreast Feeding; Lactation; Milk, Human; Adrenergic Agents; Central Nervous System Stimulants; Dopamine Agents; Sympathomimetics; Wakefulness-Promoting Agents
Melting Point>203
Physical DescriptionSolid

물리화학적 성질

끓는 점
327.6 · 327.6±17.0 °C(Predicted)
밀도
1.07 · 1.070±0.06 g/cm3(Predicted)
산도 계수 (pKa)
9.51 · 9.51±0.10(Predicted)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

Exposure Routes11-52%
Toxicity Summary · 1건

Methylphenidate blocks dopamine uptake in central adrenergic neurons by blocking dopamine transport or carrier proteins. Methylphenidate acts at the brain stem arousal system and the cerebral cortex and causes increased sympathomimetic activity in the central nervous system. Methylphenidate is a catecholamine reuptake inhibitor that indirectly increases catecholaminergic neurotransmission by inhibiting the dopamine transporter (DAT) and norepinephrine transporter (NET), which are responsible for clearing catecholamines from the synapse, particularly in the striatum and meso-limbic system.

Signs and Symptoms · 1건

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 5건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

dexmethylphenidate

DILI Positive

Oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataOral, Mouse: LD<sub>50</sub>=190mg/kg

화학 및 산업

약리 정보

ATC Code · 2건

N - Nervous system

QN - Nervous system

Protein Binding12-15% of dexmethylphenidate is protein bound. However, other studies have observed 15.2±5.2% protein binding in children and 16.2±1.1% in adults.
PharmacodynamicsDexmethylphenidate is the d-enantiomer of methylphenidate. This enantiomer is more pharmacologically active than the racemic mixture and may block norepinephrine and dopamine reuptake in synapses.
Mechanism of Action · 1건

Methylphenidate inhibits dopamine and norepinephrine reuptake transporters in synapses, especially in the thalamus and striatum. One study shows no detectable difference in the caudal prefrontal cortex of treated or untreated monkeys, though multiple rat studies show activity on the prefrontal cortex. Imaging of human brains after administration of methylphenidate shows changes to blood flow of various regions of the brain including the striatum, supplementary motor area, and posterior parietal cortex.

Biological Half-LifeThe mean terminal half life is approximately 2.2 hours. However other studies have shown 3.8-3.9 hours, or 5.96 hours after intravenous administration and 5.69 hours following an oral dose.
Metabolism/Metabolites · 2건

Dexmethylphenidate is metabolised to the inactive metabolite ritalinic acid by carboxylesterase 1A1 in the liver. Other minor pathways metabolise dexmethylphenidate to the inactive metabolites 6-oxo-methylphenidate and p-hydroxy-methylphenidate which are de-esterified and conjugated into other unknown metabolites.

epatic, methylphenidate is metabolized primarily by de-esterification to ritalinic acid (&alpha;-phenyl-2-piperidine acetic acid, PPAA), which has little to no pharmacologic activity. Route of Elimination: Renal Half Life: 2-4 hours

FDA Pharmacological Classification · 5건

M32RH9MFGP

DEXMETHYLPHENIDATE

Established Pharmacologic Class [EPC] - Central Nervous System Stimulant

관련 반응

16건
반응 기록 만들기
HRID 241544 반응식
HRID 241544생성물로
HRID 242139 반응식
HRID 242139생성물로
HRID 587133 반응식
HRID 587133생성물로
HRID 599388 반응식
HRID 599388생성물로
HRID 599389 반응식
HRID 599389반응물로
HRID 874176 반응식
HRID 874176생성물로
HRID 1019622 반응식
HRID 1019622생성물로
HRID 1020445 반응식
HRID 1020445생성물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
DTXSID
DTXSID70893769
ChEMBL
CHEMBL827
ChEBI
CHEBI:51860
UNII
M32RH9MFGP
Nikkaji
J343.157F

Physiologic Effects [PE] - Central Nervous System Stimulation

Dexmethylphenidate is a Central Nervous System Stimulant. The physiologic effect of dexmethylphenidate is by means of Central Nervous System Stimulation.

MeSH Pharmacological Classification · 2건

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.

Absorption, Distribution and Excretion · 4건

Taking dexmethylphenidate with or without food does not affect patients in a clinically relevant way. 90% of an oral dose is absorbed but as a result of hepatic first pass metabolism, oral bioavailability of dexmethylphenidate is 23% compared to l-methylphenidate with an oral bioavailability of 5%. Maximum concentration is generally reached in 1-1.5 hours.

Dexmethylphenidate is mainly eliminated renally. After 48 hours, 90% of the dose is collected in the urine and 3.3% is collected from feces.

2.65L/kg when administered intravenously.

0.40L/hr/kg following an intravenous dose and a renal clearance of 0.005L/hr/kg.

Cellular LocationsMembrane

용도 및 제조

UsesDexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment.

응용 분야

용도Treatment of attention deficit/hyperactivity disorder.

추가 설명

정의ChEBI: A methyl phenyl(piperidin-2-yl)acetate in which both stereocentres have R configuration. It is the active enantiomer in the racemic drug methylphenidate.